These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7678114)

  • 21. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
    Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
    Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia.
    Wolowiec D; Ciszak L; Kosmaczewska A; Bocko D; Teodorowska R; Frydecka I; Kuliczkowski K
    Haematologica; 2001 Dec; 86(12):1296-304. PubMed ID: 11726322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia.
    Bomstein Y; Yuklea M; Radnay J; Shapiro H; Afanasyev F; Yarkoni S; Lishner M
    Eur J Haematol; 2003 May; 70(5):290-5. PubMed ID: 12694164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2D-gel analysis of proteins in chronic lymphocytic leukemia cells and normal B-lymphocytes.
    Saunders FK; Sharrard RM; Winfield DA; Lawry J; Goepel JR; Hancock BW; Goyns MH
    Leuk Res; 1993 Mar; 17(3):223-30. PubMed ID: 7680735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.
    Castejón R; Vargas JA; Romero Y; Briz M; Muñoz RM; Durántez A
    Cytometry; 1999 Oct; 38(5):224-30. PubMed ID: 10516608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-4 and interferon gamma regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells.
    Levesque MC; Misukonis MA; O'Loughlin CW; Chen Y; Beasley BE; Wilson DL; Adams DJ; Silber R; Weinberg JB
    Leukemia; 2003 Feb; 17(2):442-50. PubMed ID: 12592345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
    Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
    Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
    Dancescu M; Rubio-Trujillo M; Biron G; Bron D; Delespesse G; Sarfati M
    J Exp Med; 1992 Nov; 176(5):1319-26. PubMed ID: 1402678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.
    Ghamlouch H; Ouled-Haddou H; Damaj G; Royer B; Gubler B; Marolleau JP
    PLoS One; 2013; 8(3):e60370. PubMed ID: 23555960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-CLL cells are capable of synthesis and secretion of both pro- and anti-angiogenic molecules.
    Kay NE; Bone ND; Tschumper RC; Howell KH; Geyer SM; Dewald GW; Hanson CA; Jelinek DF
    Leukemia; 2002 May; 16(5):911-9. PubMed ID: 11986954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.
    Chaouchi N; Wallon C; Taieb J; Auffredou MT; Tertian G; Lemoine FM; Delfraissy JF; Vazquez A
    Clin Immunol Immunopathol; 1994 Nov; 73(2):197-204. PubMed ID: 7923926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell growth-promoting activity of interferon-gamma. Mitogenic effect of the recombinant cytokine on cells from a human T-chronic lymphocytic leukemia.
    Alfinito F; Lamberti A; Capobianchi MR; Nigro M; De Rosa G; Tassone P; Turco MC; Dianzani F; Venuta S
    Leukemia; 1994 Aug; 8(8):1294-300. PubMed ID: 8057665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
    Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
    J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells.
    Müller MR; Tsakou G; Grünebach F; Schmidt SM; Brossart P
    Blood; 2004 Mar; 103(5):1763-9. PubMed ID: 14615377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
    Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
    Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.